Transgene vaccination using Ulex europaeus agglutinin I (UEA-1) for targeted mucosal immunization against HIV-1 envelope

Vaccine. 2005 May 31;23(29):3836-42. doi: 10.1016/j.vaccine.2005.02.023. Epub 2005 Mar 17.

Abstract

Receptor-mediated gene transfer using an M cell ligand has been shown to be an efficient method for mucosal DNA immunization. To investigate further into alternative M cell ligands, the plant lectin, Ulex europaeus agglutinin I (UEA-1), was tested. UEA-1 binds to human intestinal Caco-2 cells, and these cells can be transfected with poly-l-lysine (PL)-conjugated UEA-1 for expression of reporter cDNAs. When tested in vivo, mice nasally immunized with UEA-1-PL complexed to plasmid encoding HIV-1 envelope showed elevated systemic and mucosal antibody responses, and these were supported by tissue antibody-forming cells. Likewise, elevated envelope-specific CTLs were induced. Thus, UEA-1 mediated DNA delivery represents an alternative mucosal formulation for inducing humoral and cellular immunity against HIV-1.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS Vaccines / immunology*
  • Administration, Intranasal
  • Animals
  • Caco-2 Cells
  • HIV Antibodies / analysis
  • HIV Envelope Protein gp160 / genetics
  • HIV Envelope Protein gp160 / immunology*
  • HIV-1 / immunology*
  • Humans
  • Immunity, Mucosal*
  • Immunoglobulin A / analysis
  • Immunoglobulin G / blood
  • Mice
  • Mice, Inbred BALB C
  • Mucous Membrane / immunology
  • Plant Lectins / administration & dosage
  • Plant Lectins / chemistry
  • Plant Lectins / immunology*
  • T-Lymphocytes, Cytotoxic / immunology
  • Transfection
  • Ulex*
  • Vaccines, DNA / immunology*
  • Vaccines, Synthetic

Substances

  • AIDS Vaccines
  • HIV Antibodies
  • HIV Envelope Protein gp160
  • Immunoglobulin A
  • Immunoglobulin G
  • Plant Lectins
  • Ulex europaeus lectins
  • Vaccines, DNA
  • Vaccines, Synthetic